mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Ophélia Maertens et al.|Cancer Discovery|2017Cited by 110
Supplemental Figures and Table from mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Unknown|2023Cited by 0
Supplemental Figures and Table from mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Unknown|2023Cited by 0
Data from mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Unknown|2023Cited by 0
Data from mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven TumorsClare F. Malone, Karen Cichowski, Chloe E. Emerson et al.|Unknown|2023Cited by 0